ES
MARKETS / BALCAO / JUSH
BALCAO · MEDICINAL CHEMICALS & BOTANICAL PRODUCTS

Jushi Holdings Inc. JUSH

6 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$262.9M
▲ 2.1% vs FY2024
EPS · FY25
$-0.35
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
—
Net margin · FY25
-26.1%
Dividend coverage
—
Result
USD 262.9M
Revenue, FY2025 · full 6-year series below
Revenue Net income
0.080.160.240.320.3-0.1202020232025
0.080.160.240.320.3-0.1202020232025

The company lost 26 cents on every revenue dollar this year.

Per share
USD -0.35
Diluted EPS, FY2025
EPS
0.40.81.2-0.35202020232025
0.40.81.2-0.35202020232025

The company pays no cash dividend.

Profitability
—
Return on equity, FY2025
ROE
4812202020232025
4812202020232025

Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—

Growth
+26.6% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
−2.6%
+26.6%

Compound annual rates per period — left blank where the series crosses a loss.

Share base
—
Shares outstanding, FY2025
0.200.20202020232025
0.200.20202020232025

A share split breaks the comparison across the period, so we leave it out.

Balance sheet
USD 422.3M
total assets, end of FY2025
Total assetsUSD 422.3M
EquityUSD -115.3M
CashUSD 24.0M
Gross debtUSD 205.8M
Net debtUSD 181.8M
Current ratio1.03×

Net debt stands at -158% of equity.

History
6 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
Revenue $B
0.3
0.3
0.3
0.3
0.2
0.1
Operating income $B
0.0
0.0
−0.0
−0.2
−0.0
−0.0
EBITDA $B
0.0
0.0
0.0
−0.2
−0.0
−0.0
Income tax $B
0.0
0.0
0.0
0.0
0.0
0.0
Net income $B
−0.1
−0.0
−0.1
−0.2
0.0
−0.2
EPS, diluted $
−0.35
−0.25
−0.33
−1.44
−0.42
−1.94
Dividend / sh $
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
ROE %
·
·
−317.2
−176.2
11.1
·
Shares out B
·
·
0.20
0.20
·
·

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
22 of 22
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 0 failures and 0 presentation gaps.

The company

Identity as the company itself declares it to the SEC.

ActivityMedicinal Chemicals & Botanical Products
Listed onOTC market
Incorporated inoutside the United States — SEC code A1
Fiscal year endsDecember 31
SEC categoryemerging growth company
Data on record since2020

Share this section

Download image